DB&C Advisors’s Merck MRK Stock Holding History

DB&C Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$397K	Buy	3,091 +19	+0.6%	+$2.22K	0.43%	46
2026 Q1	$369K	Buy	3,072 +22	+0.7%	+$2.54K	0.48%	46
2025 Q4	$321K	Buy	+3,050	New	+$286K	0.4%	50

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DB&C Advisors's MRK Position: Q2 2026 in Review

DB&C Advisors increased its Merck (MRK) stake by 0.62% in Q2 2026, buying an estimated $2.22K and bringing the position to 3,091 shares worth $397K. The position accounts for 0.43% of the portfolio, ranked #46.

DB&C Advisors first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,828 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

DB&C Advisors held 3,091 shares of Merck worth $397K as of Q2 2026.
DB&C Advisors bought 19 Merck shares in Q2 2026, an estimated $2.22K.
Merck made up 0.43% of DB&C Advisors's portfolio in Q2 2026, its #46 holding.
DB&C Advisors first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,828 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on DB&C Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.